BCL2 and hematopoietic and lymphoid cell neoplasm: Our findings indicate that certain plasma proteins exhibit causative roles in various hematological tumors, specifically ISOC1 in 14 tumors, ADK in 11 tumors, FKBPL in 10 tumors, and BCL2 in 9 tumors.